[1] |
MARTINS PN, TULLIUS SG, MARKMANN JF. Immunosenescence and immune response in organ transplantation[J]. Int Rev Immunol, 2014, 33(3): 162- 173. DOI: 10.3109/08830185.2013.829469.
|
[2] |
DE FIJTER JW. Cancer and mTOR inhibitors in transplant recipients[J]. Transplantation, 2017, 101(1):45-55. DOI: 10.1097/TP.0000000000001447.
|
[3] |
LIM WH, ERIS J, KANELLIS J, et al. A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients[J]. Am J Transplant, 2014, 14(9): 2106-2119. DOI: 10.1111/ajt.12795.
|
[4] |
赵成江, 叶学军, 陈姣, 等.食蟹猴腹主动脉补丁缝合术后的免疫排斥反应监测[J].器官移植, 2017, 8(2): 127-131. DOI: 10.3969/j.issn.1674-7445.2017.02.007.ZHAO CJ, YE XJ, CHEN J, et al. Monitoring of immune rejection after abdominal aortic patch suture in cynomolgus monkeys[J]. Organ Transplant, 2017, 8(2): 127-131. DOI: 10.3969/j.issn.1674-7445.2017.02.007.
|
[5] |
COOPER DKC, PIERSON RN 3RD, HERING BJ, et al. Regulation of clinical xenotransplantation-time for a reappraisal[J]. Transplantation, 2017, 101(8): 1766- 1769. DOI: 10.1097/TP.0000000000001683.
|
[6] |
PHELPS CJ, KOIKE C, VAUGHT TD, et al. Production of alpha 1, 3-galactosyltransferase-deficient pigs[J]. Science, 2003, 299(5605): 411-414. doi: 10.1126/science.1078942
|
[7] |
KWON DN, LEE K, KANG MJ, et al. Production of biallelic CMP-Neu5Ac hydroxylase knock-out pigs[J]. Sci Rep, 2013, 3: 1981. DOI: 10.1038/srep01981.
|
[8] |
NIU D, WEI HJ, LIN L, et al. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9[J]. Science, 2017, 357(6357): 1303-1307. DOI: 10.1126/science.aan4187.
|
[9] |
SCOBIE L, DENNER J, SCHUURMAN HJ. Inactivation of porcine endogenous retrovirus in pigs using CRISPRCas9, editorial commentary[J]. Xenotransplantation, 2017, 24(6). DOI: 10.1111/xen.12363.
|
[10] |
COOPER DK, HARA H, EZZELARAB M, et al. The potential of genetically-engineered pigs in providing an alternative source of organs and cells for transplantation[J]. J Biomed Res, 2013, 27(4): 249-253. DOI: 10.7555/JBR.27.20130063.
|
[11] |
KIM GA, LEE EM, JIN JX, et al. Generation of CMAHKO/GTKO/shTNFRI-Fc/HO-1 quadruple gene modified pigs[J]. Transgenic Res, 2017, 26(4): 435-445. DOI: 10.1007/s11248-017-0021-6.
|
[12] |
HOLT CD. Overview of immunosuppressive therapy in solid organ transplantation[J]. Anesthesiol Clin, 2017, 35(3): 365-380. DOI: 10.1016/j.anclin.2017.04.001.
|
[13] |
ILYAS M, COLEGIO OR, KAPLAN B, et al. Cutaneous toxicities from transplantation-related medications[J]. Am J Transplant, 2017, 17(11): 2782-2789. DOI: 10.1111/ajt.14337.
|
[14] |
EZZELARAB MB, EKSER B, ECHEVERRI G, et al. Costimulation blockade in pig artery patch xenotransplantation - a simple model to monitor the adaptive immune response in nonhuman primates[J]. Xenotransplantation, 2012, 19(4): 221-232. DOI: 10.1111/j.1399-3089.2012.00711.x.
|
[15] |
DALLMAN MJ. Cytokines and transplantation: Th1/ Th2 regulation of the immune response to solid organ transplants in the adult[J]. Curr Opin Immunol, 1995, 7(5): 632-638. doi: 10.1016/0952-7915(95)80069-7
|
[16] |
NICKERSON P, STEURER W, STEIGER J, et al. Cytokines and the Th1/Th2 paradigm in transplantation[J]. Curr Opin Immunol, 1994, 6(5): 757-764. doi: 10.1016/0952-7915(94)90081-7
|
[17] |
ROSSI JF, LU ZY, JOURDAN M, et al. Interleukin-6 as a therapeutic target[J]. Clin Cancer Res, 2015, 21(6): 1248-1257. DOI: 10.1158/1078-0432.CCR-14-2291.
|
[18] |
ZHANG W, HE J. Interleukin-6 is a key factor for immunoglobulin-like transcript-4-mediated immune injury in sepsis[J]. J Intensive Care, 2018, 6:22. DOI: 10.1186/s40560-018-0294-8.
|
[19] |
CHAE MS, MOON KU, CHUNG HS, et al. Serum interleukin-6 and tumor necrosis factor-α are associated with early graft regeneration after living donor livertransplantation[J]. PLoS One, 2018, 13(4): e0195262. DOI: 10.1371/journal.pone.0195262.
|
[20] |
VALPIONE S, PASQUALI S, CAMPANA LG, et al. Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade[J]. J Transl Med, 2018, 16(1): 94. DOI: 10.1186/s12967-018- 1467-x.
|
[21] |
G O M E Z - R O D R I G U E Z J, W O H L F E RT E A, HANDON R, et al. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells[J]. J Exp Med, 2014, 211(3): 529-543. DOI: 10.1084/jem.20131459.
|
[22] |
NAKAGIRI T, INOUE M, MINAMI M, et al. Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation[J]. Transplant Proc, 2012, 44(4): 1035- 1040. DOI: 10.1016/j.transproceed.2011.12.032.
|
[23] |
秦建杰, 吕凌.白细胞介素17在器官移植排斥中的作用及机制[J].临床肝胆病杂志, 2012, 28(11): 812-814. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_lcgdbzz201211003QIN JJ, LYU L. The role and molecular mechanism of interleukin-17 in organ transplant rejection[J]. J Clin Hepatol, 2012, 28(11): 812-814. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_lcgdbzz201211003
|